Bone grafts, bone substitutes and orthobiologics the bridge between basic science and clinical advancements in fracture healing

Organogenesis

Volumn 8, Issue 4, 2012, Pages 114-124

  Roberts, Timothy T ^a   Rosenbaum, Andrew J ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

Bone graft; Bone graft substitute; Fractures; Nonunion; Orthobiologics

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CALCIUM SULFATE; OSTEOGENIC PROTEIN 1; PARATHYROID HORMONE; VASCULOTROPIN;

ARTICLE; BONE CONDUCTION; BONE DEVELOPMENT; BONE GRAFT; BONE MARROW BIOPSY; BONE MINERALIZATION; BONE PROSTHESIS; CORTICAL BONE; COST; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; THROMBOCYTE RICH PLASMA; TRABECULAR BONE; VASCULARIZATION;

BONE GRAFT; BONE GRAFT SUBSTITUTE; FRACTURES; NONUNION; ORTHOBIOLOGICS;

ANIMALS; BIOLOGICAL FACTORS; BONE SUBSTITUTES; BONE TRANSPLANTATION; FRACTURE HEALING; FRACTURES, UNUNITED; HUMANS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84874616029     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.23306     Document Type: Article

References (31)

1. Kwong FNK, Harris MB. Recent developments in the biology of fracture repair. J Am Acad Orthop Surg 2008; 16:619-25; PMID:18978283.
2. Fayaz HC, Giannoudis PV, Vrahas MS, Smith RM, Moran C, Pape HC, et al. The role of stem cells in fracture healing and nonunion. Int Orthop 2011; 35:1587- 97; PMID:21863226; http://dx.doi.org/10.1007/ s00264-011-1338-z.
3. Russell AT, Taylor CJ, Lavelle DG. (1991) Fractures of tibia and fibula. In: Bucholz RW, Heckman JD, Court- Brown CM (eds) Fractures in Adults, Rockwood and Green, vol 3. pp 1915- 1982.
4. Taylor CJ. (1992) Delayed union and nonunion of fractures. In: Crenshaw AH (ed) Campbell's Operative Orthopaedics, vol 28.Mosby, pp 1287-1345.
5. Khan SN, Cammisa FP Jr., Sandhu HS, Diwan AD, Girardi FP, Lane JM. The biology of bone grafting. J Am Acad Orthop Surg 2005; 13:77-86; PMID:15712985.
6. McKee MD. Management of segmental bony defects: the role of osteoconductive orthobiologics. J Am Acad Orthop Surg 2006; 14(10 Spec No.):S163-7; PMID:17003191.
7. Flynn JM. "Fracture Repair and Bone Grafting." OKU 10: Orthopaedic Knowledge Update. Rosemont, IL: American Academy of Orthopaedic Surgeons, 2011. 11-21.
8. Oakes DA, Cabanela ME. Impaction bone grafting for revision hip arthroplasty: biology and clinical applications. J Am Acad Orthop Surg 2006; 14:620-8; PMID:17030595.
9. Bae DS, Waters PM. Free Vascularized Fibula Grafting: Principles, Techniques, and Applications in Pediatric Orthopaedics. Orthopaedic Journal at Harvard Medical School 2006; 8:86-9.
10. Laurencin CT. "Musculoskeletal Allograft Tissue Banking and Safety." Bone Graft Substitutes . W. Conshohocken, PA: ASTM International, 2003; 30-67.
11. Hak DJ. The use of osteoconductive bone graft substitutes in orthopaedic trauma. J Am Acad Orthop Surg 2007; 15:525-36; PMID:17761609.
12. Bohner M. Design of ceramic-based cements and putties for bone graft substitution. Eur Cell Mater 2010; 20:1-12; PMID:20574942.
13. Synthes International. Advertisement. Norian SRS. N.p., n.d. Web. 7 Oct. 2012. http://www.synthes. com/sites/intl/Products/Biomaterials/Trauma/Pages/ Norian-SRS.aspx.
14. Mendenhall S. "Bone graft and bone substitues." Orthopedic Network News. Mendenhall Associates, Inc.,Nov. 2008. Web. 30 Sept. 2012. http://old.orthopedicnetworknews. com/.
15. Obremskey WT, Marotta JS, Yaszemski MJ, Churchill LR, Boden SD, Dirschl DR. Symposium. The introduction of biologics in orthopaedics: issues of cost, commercialism, and ethics. J Bone Joint Surg Am 2007; 89:1641-9; PMID:17606804; http://dx.doi. org/10.2106/JBJS.F.01185.
16. Rihn JA, Gates C, Glassman SD, Phillips FM, Schwender JD, Albert TJ. The use of bone morphogenetic protein in lumbar spine surgery. J Bone Joint Surg Am 2008; 90:2014-25; PMID:18762664.
17. Milano F, van Baal JW, Buttar NS, Rygiel AM, de Kort F, DeMars CJ, et al. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology 2007; 132:2412-21; PMID:17570215; http://dx.doi. org/10.1053/j.gastro.2007.03.026.
18. Kodach LL, Wiercinska E, de Miranda NF, Bleuming SA, Musler AR, Peppelenbosch MP, et al. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology 2008; 134:1332-41; PMID:18471510; http://dx.doi. org/10.1053/j.gastro.2008.02.059.
19. Even J, Eskander M, Kang J. Bone morphogenetic protein in spine surgery: current and future uses. J Am Acad Orthop Surg 2012; 20:547-52; PMID:22941797; http://dx.doi.org/10.5435/JAAOS-20-09-547.
20. Khan SN, Fraser JF, Sandhu HS, Cammisa FP Jr., Girardi FP, Lane JM. Use of osteopromotive growth factors, demineralized bone matrix, and ceramics to enhance spinal fusion. J Am Acad Orthop Surg 2005; 13:129-37; PMID:15850370.
21. Friedlaeder GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, et al. Osteogenic Protein- (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions. The Journal of Bone and Joint Surgery 2001; 83-A(Supplement 1, Part2):151-8; PMID:11712836.
22. Cahill KS, Chi JH, Day A, Claus EB. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. Jama 2009; 302:58-66; PMID:19567440; http://dx.doi.org/10. 1001/jama.2009.956.
23. Einhorn TA, Lee CA. Bone regeneration: new findings and potential clinical applications. J Am Acad Orthop Surg 2001; 9:157-65; PMID:11421573.
24. Kaback LA, Soung Y, Naik A, Geneau G, Schwarz EM, Rosier RN, et al. Teriparatide (1-34 human PTH) regulation of osterix during fracture repair. J Cell Biochem 2008; 105:219-26; PMID:18494002; http://dx.doi. org/10.1002/jcb.21816.
25. Bostrum MPG, Seigerman DA. The Clinical Use of Allografts, Demineralized Bone Matrices, Synthetic Bone raft Substitutes and Osteoinductive Growth Factors: A Survey Study. The Hospital for Special Surgery Journal 2005; 1:9-18.
26. "BMP1 Bone Morphogenetic Protein 1." National Center for Biotechnology Information. U.S. National Library of Medicine, 12 Sept. 2012 [updated]. Web.
27. Oct. 2012. http://www.ncbi.nlm.nih.gov/sites/ent rez?Db=gene&Cmd= ShowDetailView&TermToSear ch=649.
28. Kan L, Hu M, Gomes WA, Kessler JA. Transgenic Mice Overexpressing BMP4 Develop a Fibrodysplasia Ossificans Progressiva (FOP)-Like Phenotype. Am J Pathol 2004; 165: 1107-15. (Pubitemid 39297718)
29. Meynard D, Vaja V, Sun CC, Corradini E, Chen S, López-Otín C, et al. Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. Blood 2011; 118:747-56; PMID:21622652; http://dx.doi. org/10.1182/blood-2011-04- 348698.
30. Kumar V, Abbas AK, Fausto N, Aster J. (2009).Robbins and Coltran Pathologic Basis of Disease. Saunders; 8 edition (2009) pp. 88-89.
31. Rosenbloom AL. Insulin-like growth factor-I (rhIGF-I) therapy of short stature. J Pediatr Endocrinol Metab 2008; 21:301-15. (Pubitemid 351802721)